Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Stephanie Toepfer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Mucor, Azoles, Antifungal Agents, Drug Resistance, Fungal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science, Pfizer Austria, Royal Society of New Zealand.
Abstract (Originalsprache)
Objectives
This study aims to characterize the possible contribution of eight pleiotropic drug resistance (PDR) transporters to the azole resistance phenotype of Mucor lusitanicus.
Methods
Gene expression analysis (RNA-sequencing and RT-qPCR) was performed on M. lusitanicus CBS277.49 cells exposed to three different types of azoles (4.0 mg/L). C-terminally GFP-tagged M. lusitanicus PDR transporters were overexpressed in the hypersensitive model host, Saccharomyces cerevisiae ADΔΔ. Their efflux pump functions were evaluated by determining the azole susceptibilities of the PDR transporter overexpressing cells and measuring their plasma membrane ATPase activities.
Results
M. lusitanicus PDR transporters separated into two phylogenetic clusters: A (pdr1, pdr6-8) and B (pdr2-5). RNA-sequencing and RT-qPCR revealed strong up-regulation of pdr1 and pdr6, but down-regulation of pdr7 and pdr8 in response to 80 min exposures of 4.0 mg/L voriconazole, isavuconazole or posaconazole. The expression of Pdr6 and Pdr7 in S. cerevisiae ADΔΔ increased its resistance to short- and mid-length tailed azoles. Pdr1 and Pdr8 expression, however, conferred pan-azole resistance including long-tailed azoles such as itraconazole and posaconazole. No efflux pump function and ATPase activity were detected for Pdr3 and Pdr5. The ATPase activities of Pdr1, Pdr6, Pdr7 and Pdr8 were comparable to Candida albicans Cdr1 expressed in ADΔΔ.
Conclusions
All Mucor cluster A PDR transporters are multidrug efflux pumps, but Pdr1 and Pdr6 are possibly the major contributors to the innate azole resistance phenotype of M. lusitanicus.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
- Faculty of Dentistry, Sir John Walsh Research Institute, University of Otago, Dunedin, New Zealand.
- Max Planck Institute for Infection Biology, Berlin, Germany.
ORCID-Profile: Jasper E James
Förderung
- Austrian Science
- Pfizer Austria
- Royal Society of New Zealand
Zitieren
APA
Toepfer, S., Lamping, E., James, J. E., Zenz, L. M., Loacker-Schoech, J., Rosam, K., Majer, O., & Lackner, M. (2025). Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf343
Vancouver
Toepfer S, Lamping E, James JE, Zenz LM, Loacker-Schoech J, Rosam K, et al. Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf343
BibTeX
@article{Toepfer2025,
author = {Toepfer, Stephanie and Lamping, Erwin and James, Jasper E and Zenz, Lisa-Maria and Loacker-Schoech, Julia and Rosam, Katharina and Majer, Olivia and Lackner, Michaela},
title = {Multidrug efflux pumps and innate azole resistance of Mucor lusitanicus},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf343}
}
EUVIMED